Hubert Fernandez
Hubert Fernandez
Director, Center for Neurological Restoration, Cleveland Clinic
Email verificata su
Citata da
Citata da
Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): scale presentation and clinimetric testing results
CG Goetz, BC Tilley, SR Shaftman, GT Stebbins, S Fahn, ...
Movement disorders: official journal of the Movement Disorder Society 23 (15 …, 2008
Genome-wide association study reveals genetic risk underlying Parkinson's disease
J Simon-Sanchez, C Schulte, JM Bras, M Sharma, JR Gibbs, D Berg, ...
Nature genetics 41 (12), 1308, 2009
Rotenone, paraquat, and Parkinson’s disease
CM Tanner, F Kamel, GW Ross, JA Hoppin, SM Goldman, M Korell, ...
Environmental health perspectives 119 (6), 866-872, 2011
The parkinson progression marker initiative (PPMI)
K Marek, D Jennings, S Lasch, A Siderowf, C Tanner, T Simuni, C Coffey, ...
Progress in neurobiology 95 (4), 629-635, 2011
Cognition and mood in Parkinson's disease in subthalamic nucleus versus globus pallidus interna deep brain stimulation: the COMPARE trial
MS Okun, HH Fernandez, SS Wu, L Kirsch‐Darrow, D Bowers, F Bova, ...
Annals of Neurology: Official Journal of the American Neurological …, 2009
Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study
CW Olanow, K Kieburtz, P Odin, AJ Espay, DG Standaert, HH Fernandez, ...
The Lancet Neurology 13 (2), 141-149, 2014
Genome-wide genotyping in Parkinson's disease and neurologically normal controls: first stage analysis and public release of data
HC Fung, S Scholz, M Matarin, J Simón-Sánchez, D Hernandez, A Britton, ...
The Lancet Neurology 5 (11), 911-916, 2006
Diagnostic criteria for psychosis in Parkinson's disease: report of an NINDS, NIMH work group
B Ravina, K Marder, HH Fernandez, JH Friedman, W McDonald, ...
Movement Disorders 22 (8), 1061-1068, 2007
Management of referred deep brain stimulation failures: a retrospective analysis from 2 movement disorders centers
MS Okun, M Tagliati, M Pourfar, HH Fernandez, RL Rodriguez, ...
Archives of neurology 62 (8), 1250-1255, 2005
Dissociating apathy and depression in Parkinson disease
L Kirsch-Darrow, HF Fernandez, M Marsiske, MS Okun, D Bowers
Neurology 67 (1), 33-38, 2006
Aspiration and swallowing in Parkinson disease and rehabilitation with EMST: a randomized trial
MS Troche, MS Okun, JC Rosenbek, N Musson, HH Fernandez, ...
Neurology 75 (21), 1912-1919, 2010
Donepezil for dementia in Parkinson’s disease: a randomised, double blind, placebo controlled, crossover study
B Ravina, M Putt, A Siderowf, JT Farrar, M Gillespie, A Crawley, ...
Journal of Neurology, Neurosurgery & Psychiatry 76 (7), 934-939, 2005
A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease
IH Richard, MP McDermott, R Kurlan, JM Lyness, PG Como, N Pearson, ...
Neurology 78 (16), 1229-1236, 2012
Mechanisms underlying dopamine-mediated reward bias in compulsive behaviors
V Voon, M Pessiglione, C Brezing, C Gallea, HH Fernandez, RJ Dolan, ...
Neuron 65 (1), 135-142, 2010
Association of cerebrospinal fluid β-amyloid 1-42, T-tau, P-tau181, and α-synuclein levels with clinical features of drug-naive patients with early Parkinson disease
JH Kang, DJ Irwin, AS Chen-Plotkin, A Siderowf, C Caspell, CS Coffey, ...
JAMA neurology 70 (10), 1277-1287, 2013
SNCA variants are associated with increased risk for multiple system atrophy
SW Scholz, H Houlden, C Schulte, M Sharma, A Li, D Berg, A Melchers, ...
Annals of Neurology: Official Journal of the American Neurological …, 2009
A controlled trial of rotigotine monotherapy in early Parkinson's disease.
Parkinson Study Group
Archives of neurology 60 (12), 1721, 2003
Quetiapine for the treatment of drug‐induced psychosis in Parkinson's disease
HH Fernandez, JH Friedman, C Jacques, M Rosenfeld
Movement disorders: official journal of the Movement Disorder Society 14 (3 …, 1999
Analysis of the PINK1 gene in a large cohort of cases with Parkinson disease
E Rogaeva, J Johnson, AE Lang, C Gulick, K Gwinn-Hardy, T Kawarai, ...
Archives of neurology 61 (12), 1898-1904, 2004
Pathophysiology and treatment of psychosis in Parkinson’s disease
LB Zahodne, HH Fernandez
Drugs & aging 25 (8), 665-682, 2008
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20